251 related articles for article (PubMed ID: 8341112)
1. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
[TBL] [Abstract][Full Text] [Related]
3. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352
[TBL] [Abstract][Full Text] [Related]
4. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
[TBL] [Abstract][Full Text] [Related]
5. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
6. [Neurological manifestations of leprosy].
Grimaud J; Vallat JM
Rev Neurol (Paris); 2003 Nov; 159(11):979-95. PubMed ID: 14710019
[TBL] [Abstract][Full Text] [Related]
7. Skin, dartos, and nerve biopsies as aids to diagnosis in leprosy.
Pandya NJ
Plast Reconstr Surg; 1974 Jul; 54(1):70-80. PubMed ID: 4598943
[No Abstract] [Full Text] [Related]
8. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.
Bahia El Idrissi N; Iyer AM; Ramaglia V; Rosa PS; Soares CT; Baas F; Das PK
PLoS One; 2017; 12(5):e0177815. PubMed ID: 28505186
[TBL] [Abstract][Full Text] [Related]
9. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.
Shetty VP; Uplekar MW; Antia NH
Acta Neuropathol; 1994; 88(4):300-6. PubMed ID: 7839822
[TBL] [Abstract][Full Text] [Related]
11. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
[TBL] [Abstract][Full Text] [Related]
12. Bacillary and histopathological findings in the peripheral nerves of armadillos experimentally infected with M. leprae.
McDougall AC
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):260-2. PubMed ID: 9251602
[No Abstract] [Full Text] [Related]
13. A clinical, immunological, and histological study of neuritic leprosy patients.
Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
[TBL] [Abstract][Full Text] [Related]
14. Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.
van der Vliet GM; Cho SN; Kampirapap K; van Leeuwen J; Schukkink RA; van Gemen B; Das PK; Faber WR; Walsh GP; Klatser PR
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):396-403. PubMed ID: 9030105
[TBL] [Abstract][Full Text] [Related]
15. The value of IgM antibodies to PGL-I in the diagnosis of leprosy.
Lefford MJ; Hunegnaw M; Siwik E
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):432-40. PubMed ID: 1890367
[TBL] [Abstract][Full Text] [Related]
16. Classification of nerves is modified by the delayed recognition of Mycobacterium leprae.
Ridley DS; Ridley MJ
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):596-606. PubMed ID: 3546549
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy.
Barros U; Shetty VP; Antia NH
Acta Neuropathol; 1987; 73(4):387-92. PubMed ID: 2441563
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease.
Rao PN; Pratap D; Ramana Reddy AV; Sujai S
Indian J Dermatol Venereol Leprol; 2006; 72(3):207-10. PubMed ID: 16766835
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy.
Martinez AN; Britto CF; Nery JA; Sampaio EP; Jardim MR; Sarno EN; Moraes MO
J Clin Microbiol; 2006 Sep; 44(9):3154-9. PubMed ID: 16954241
[TBL] [Abstract][Full Text] [Related]
20. The role of nerve biopsies in the diagnosis and management of leprosy.
Nilsen R; Mengistu G; Reddy BB
Lepr Rev; 1989 Mar; 60(1):28-32. PubMed ID: 2725169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
